BlackRock’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $395K | Sell |
361,983
-1,309,872
| -78% | -$1.43M | ﹤0.01% | 4430 |
|
|
2025
Q1 | $1.63M | Sell |
1,671,855
-28,577
| -2% | -$27.8K | ﹤0.01% | 4009 |
|
|
2024
Q4 | $2.52M | Buy |
1,700,432
+63,382
| +4% | +$93.8K | ﹤0.01% | 3922 |
|
|
2024
Q3 | $3.47M | Buy |
1,637,050
+49,326
| +3% | +$105K | ﹤0.01% | 3789 |
|
|
2024
Q2 | $3.87M | Buy |
1,587,724
+1,422,932
| +863% | +$3.47M | ﹤0.01% | 3731 |
|
|
2024
Q1 | $1.07M | Buy |
164,792
+92,564
| +128% | +$600K | ﹤0.01% | 4126 |
|
|
2023
Q4 | $279K | Sell |
72,228
-4,885
| -6% | -$18.9K | ﹤0.01% | 4483 |
|
|
2023
Q3 | $165K | Buy |
77,113
+3,132
| +4% | +$6.7K | ﹤0.01% | 4659 |
|
|
2023
Q2 | $226K | Buy |
73,981
+34,987
| +90% | +$107K | ﹤0.01% | 4617 |
|
|
2023
Q1 | $101K | Buy |
38,994
+456
| +1% | +$1.19K | ﹤0.01% | 4866 |
|
|
2022
Q4 | $79K | Sell |
38,538
-109,471
| -74% | -$224K | ﹤0.01% | 5026 |
|
|
2022
Q3 | $668K | Sell |
148,009
-35,948
| -20% | -$162K | ﹤0.01% | 4541 |
|
|
2022
Q2 | $752K | Sell |
183,957
-1,099,588
| -86% | -$4.5M | ﹤0.01% | 4559 |
|
|
2022
Q1 | $5.65M | Buy |
1,283,545
+7,337
| +0.6% | +$32.3K | ﹤0.01% | 3814 |
|
|
2021
Q4 | $15.2M | Buy |
1,276,208
+906,247
| +245% | +$10.8M | ﹤0.01% | 3371 |
|
|
2021
Q3 | $6.35M | Buy |
369,961
+4,098
| +1% | +$70.3K | ﹤0.01% | 3808 |
|
|
2021
Q2 | $6.38M | Buy |
+365,863
| New | +$6.38M | ﹤0.01% | 3736 |
|